Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Incorporating KRAS as a novel biomarker: Challenges and opportunities

Prof Ales Ryska - Charles University, Prague, Czech Republic
Incorporating KRAS as a novel biomarker: Challenges and opportunities ( Prof Ales Ryska - Charles University, Prague, Czech Republic )
29 Mar 2021

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions

Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions ( Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro )
29 Mar 2021

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy

Prof Andrea Filippi - University of Pavia, Pavia, Italy
Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy ( Prof Andrea Filippi - University of Pavia, Pavia, Italy )
26 Mar 2021

Cancer Genomics in Africa today

Dr Solomon Rotimi - Covenant University, Ota, Nigeria
Cancer Genomics in Africa today ( Dr Solomon Rotimi - Covenant University, Ota, Nigeria )
23 Mar 2021

OncoAlert and ecancer weekly roundup for March 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Mar 2021

Challenges and solutions in PD-L1 testing in NSCLC

Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France
Challenges and solutions in PD-L1 testing in NSCLC ( Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France )
5 Mar 2021

Managing immune-related adverse events

Catherine Cochez - CHU Strasbourg, France
Managing immune-related adverse events ( Catherine Cochez - CHU Strasbourg, France )
5 Mar 2021

ERAS in gynaecological oncology from developed to developing countries

Prof Geetu Bhandoria - Command Hospital, Kolkata, India
ERAS in gynaecological oncology from developed to developing countries ( Prof Geetu Bhandoria - Command Hospital, Kolkata, India )
4 Mar 2021

Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)

Dr Giuseppe Giaccone, Dr Marina Garassino
Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE) ( Dr Giuseppe Giaccone, Dr Marina Garassino )
2 Mar 2021

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma

Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )
26 Feb 2021

SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma

Dr Sia Daneshmand - University of Southern California, Los Angeles, USA
SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )
24 Feb 2021

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC

Prof Hope Rugo - University of California San Francisco, San Francisco, USA
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )
24 Feb 2021